Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple calcium shot cut C-Section bleeding?

NCT ID NCT07217899

Recruiting now Disease control Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study tests whether giving a single dose of calcium gluconate before a cesarean delivery can reduce blood loss in women at high risk for heavy bleeding. Researchers will compare calcium gluconate to a placebo in 140 pregnant volunteers. The goal is to see if this simple, inexpensive drug can prevent dangerous bleeding and the need for transfusions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
calcium gluconate
What this could lead to
If it works, this could offer a simple, low-cost way to reduce dangerous bleeding during cesarean deliveries.
What could go wrong
This is a small, early-phase trial (140 people) testing a single dose. Results may not confirm benefit, and the effect on bleeding may be minimal.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD LOSS, POSTOPERATIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Blood Loss, Surgical Postoperative Hemorrhage Uterine Inertia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD LOSS, POSTOPERATIVE BLOOD LOSS, SURGICAL UTERINE ATONY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Michigan

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.